AQA
LMAT icon

Alpha Quant Advisors’s LeMaitre Vascular LMAT Stock Holding History

Alpha Quant Advisors’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$7K Hold
218
– – 0.01% 277
2018
Q4 		$5K Buy
+218
New +$5.95K 0.01% 336

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Alpha Quant Advisors's LMAT Position: Q1 2019 in Review

Alpha Quant Advisors held its LeMaitre Vascular (LMAT) position steady in Q1 2019 at 218 shares worth $7K. The position accounts for 0.01% of the portfolio, ranked #277.

Alpha Quant Advisors first reported a position in LMAT in Q4 2018 and has held it in 2 quarters since. 155 funds tracked by Wall St. Rank hold LMAT as of Q1 2019.

  • Alpha Quant Advisors held 218 shares of LeMaitre Vascular worth $7K as of Q1 2019.
  • Alpha Quant Advisors left its LeMaitre Vascular share count unchanged in Q1 2019.
  • LeMaitre Vascular made up 0.01% of Alpha Quant Advisors's portfolio in Q1 2019, its #277 holding.
  • Alpha Quant Advisors first reported a position in LeMaitre Vascular in Q4 2018 and has held it in 2 quarters since.
  • 155 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2019.

Based on Alpha Quant Advisors's 13F filing for Q1 2019, filed 8 May 2019.